Andrey A. Poloznikov
13-4 Myasnitskaya Street
Moscow, MOW 117997, Russian Federation
Moscow, MOW 117997, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
FUNCTIONAL ANALYSIS OF BIPARTITE NRF2 ACTIVATORS THAT OVERCOME FEEDBACK REGULATION FOR AGE-RELATED CHRONIC DISEASES.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines.
Journal: Frontiers in molecular biosciences
Published: November 20, 2024
ELOVL5 and IGFBP6 genes modulate sensitivity of breast cancer cells to ferroptosis.
Journal: Frontiers in molecular biosciences
Published: October 20, 2022
Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2.
Journal: Molecules (Basel, Switzerland)
Published: December 27, 2021
Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors.
Journal: Antioxidants (Basel, Switzerland)
Published: December 08, 2021
9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells.
Journal: Frontiers in pharmacology
Published: September 14, 2021
Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 01, 2021
Identification of a potent Nrf2 displacement activator among aspirin-containing prodrugs.
Journal: Neurochemistry international
Published: July 06, 2021
Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue.
Journal: Frontiers in aging neuroscience
Published: February 27, 2021
Effect of the Expression of ELOVL5 and IGFBP6 Genes on the Metastatic Potential of Breast Cancer Cells.
Journal: Frontiers in genetics
Published: February 17, 2021
Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 01, 2020
Last Updated: 09/26/2026